<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">nnp</journal-id><journal-title-group><journal-title xml:lang="en">Neurology, Neuropsychiatry, Psychosomatics</journal-title><trans-title-group xml:lang="ru"><trans-title>Неврология, нейропсихиатрия, психосоматика</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2074-2711</issn><issn pub-type="epub">2310-1342</issn><publisher><publisher-name>"IMA-Press", LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/2074-2711-20234-100-104</article-id><article-id custom-type="elpub" pub-id-type="custom">nnp-2066</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group></article-categories><title-group><article-title>The role of trimethylamine-N-oxide in the development of cerebrovascular disease (brief review)</article-title><trans-title-group xml:lang="ru"><trans-title>Роль триметиламин-N-оксида в развитии цереброваскулярных заболеваний  (краткий обзор)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1001-2024</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кутлубаев</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kutlubaev</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мансур Амирович Кутлубаев</p><p>450008, Уфа, ул. Ленина, 3</p></bio><bio xml:lang="en"><p>Mansur Amirovich Kutlubaev</p><p>3, Lenina St., Ufa 450008</p></bio><email xlink:type="simple">mansur.kutlubaev@yahoo.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8342-3943</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рахматуллин</surname><given-names>А. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Rakhmatullin</surname><given-names>A. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>450008, Уфа, ул. Ленина, 3</p></bio><bio xml:lang="en"><p>3, Lenina St., Ufa 450008</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4671-9040</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кутлубаева</surname><given-names>Р. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Kutlubaeva</surname><given-names>R. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>450008, Уфа, ул. Ленина, 3</p></bio><bio xml:lang="en"><p>3, Lenina St., Ufa 450008</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Башкирский государственный медицинский университет» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Bashkir State Medical University, Ministry of Health of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>15</day><month>08</month><year>2023</year></pub-date><volume>15</volume><issue>4</issue><fpage>100</fpage><lpage>104</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Kutlubaev M.A., Rakhmatullin A.R., Kutlubaeva R.F., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Кутлубаев М.А., Рахматуллин А.Р., Кутлубаева Р.Ф.</copyright-holder><copyright-holder xml:lang="en">Kutlubaev M.A., Rakhmatullin A.R., Kutlubaeva R.F.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://nnp.ima-press.net/nnp/article/view/2066">https://nnp.ima-press.net/nnp/article/view/2066</self-uri><abstract><p>Trimethylamine-N-oxide (TMO) is one of the best studied metabolites of the gut microbiota. It increases the risk of stroke and dyscirculatory encephalopathy, independent of traditional cardiovascular risk factors. The mechanisms of the negative effects of TMO on the cardiovascular system are related to the acceleration of atherosclerosis progression, platelet activation, and the development of aseptic inflammation. Currently, elevated TMO levels are an indication for a strict diet with restriction of foods rich in TMO precursors. Future research should clarify the role of TMO in the development of cerebrovascular disease (CVD). It is necessary to continue the investigation of new compounds that can reduce TMO levels in patients at high risk for developing CVD.</p></abstract><trans-abstract xml:lang="ru"><p>Триметиламин-N-оксид (ТМО) является одним из наиболее изученных метаболитов кишечной микрофлоры. Он повышает риск развития инсульта и дисциркуляторной энцефалопатии вне зависимости от традиционных факторов сердечно-сосудистого риска. Механизмы негативного влияния ТМО на сердечно-сосудистую систему связаны с увеличением скорости прогрессирования атеросклероза, активацией тромбоцитов и развитием асептического воспаления. В настоящее время повышение уровня ТМО является показанием для соблюдения строгой диеты с ограничением продуктов, богатых предшественниками ТМО. Будущие исследования должны уточнить роль ТМО в развитии цереброваскулярного заболевания (ЦВЗ). Необходимо продолжить изучение новых соединений для снижения уровня ТМО у пациентов с высоким риском развития ЦВЗ.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>триметиламин-N-оксид</kwd><kwd>инсульт</kwd><kwd>кишечная микробиота</kwd><kwd>метаболиты</kwd><kwd>атеросклероз</kwd></kwd-group><kwd-group xml:lang="en"><kwd>trimethylamine-N-oxide</kwd><kwd>stroke</kwd><kwd>gut microbiota</kwd><kwd>metabolites</kwd><kwd>atherosclerosis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Mitrea L, Nemes SA, Szabo K, et al. Guts Imbalance Imbalances the Brain: A Review of Gut Microbiota Association With Neurological and Psychiatric Disorders. Front Med (Lausanne). 2022 Mar 31;9:813204. doi: 10.3389/fmed.2022.813204</mixed-citation><mixed-citation xml:lang="en">Mitrea L, Nemes SA, Szabo K, et al. Guts Imbalance Imbalances the Brain: A Review of Gut Microbiota Association With Neurological and Psychiatric Disorders. Front Med (Lausanne). 2022 Mar 31;9:813204. doi: 10.3389/fmed.2022.813204</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Valdes AM, Walter J, Segal E, Spector TD. Role of the gut microbiota in nutrition and health. BMJ. 2018 Jun 13;361:k2179. doi: 10.1136/bmj.k2179</mixed-citation><mixed-citation xml:lang="en">Valdes AM, Walter J, Segal E, Spector TD. Role of the gut microbiota in nutrition and health. BMJ. 2018 Jun 13;361:k2179. doi: 10.1136/bmj.k2179</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Peh A, O’Donnell JA, Broughton BRS, Marques FZ. Gut Microbiota and Their Metabolites in Stroke: A Double-Edged Sword. Stroke. 2022 May;53(5):1788-801. doi: 10.1161/STROKEAHA.121.036800. Epub 2022 Feb 9.</mixed-citation><mixed-citation xml:lang="en">Peh A, O’Donnell JA, Broughton BRS, Marques FZ. Gut Microbiota and Their Metabolites in Stroke: A Double-Edged Sword. Stroke. 2022 May;53(5):1788-801. doi: 10.1161/STROKEAHA.121.036800. Epub 2022 Feb 9.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Konieczny RA, Kuliczkowski W. Trimethylamine N-oxide in cardiovascular disease. Adv Clin Exp Med. 2022 Aug;31(8):913- 25. doi: 10.17219/acem/147666</mixed-citation><mixed-citation xml:lang="en">Konieczny RA, Kuliczkowski W. Trimethylamine N-oxide in cardiovascular disease. Adv Clin Exp Med. 2022 Aug;31(8):913- 25. doi: 10.17219/acem/147666</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Obeid R, Awwad HM, Rabagny Y, et al. Plasma trimethylamine N-oxide concentration is associated with choline, phospholipids, and methyl metabolism. Am J Clin Nutr. 2016 Mar;103(3):703-11. doi: 10.3945/ajcn.115.121269. Epub 2016 Feb 10.</mixed-citation><mixed-citation xml:lang="en">Obeid R, Awwad HM, Rabagny Y, et al. Plasma trimethylamine N-oxide concentration is associated with choline, phospholipids, and methyl metabolism. Am J Clin Nutr. 2016 Mar;103(3):703-11. doi: 10.3945/ajcn.115.121269. Epub 2016 Feb 10.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Gatarek P, Kaluzna-Czaplinska J. Trimethylamine N-oxide (TMAO) in human health. EXCLI J. 2021 Feb 11;20:301-19. doi: 10.17179/excli2020-3239</mixed-citation><mixed-citation xml:lang="en">Gatarek P, Kaluzna-Czaplinska J. Trimethylamine N-oxide (TMAO) in human health. EXCLI J. 2021 Feb 11;20:301-19. doi: 10.17179/excli2020-3239</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Bennett BJ, de Aguiar Vallim TQ, Wang Z, et al. Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab. 2013 Jan 8;17(1):49-60. doi: 10.1016/j.cmet.2012.12.011</mixed-citation><mixed-citation xml:lang="en">Bennett BJ, de Aguiar Vallim TQ, Wang Z, et al. Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab. 2013 Jan 8;17(1):49-60. doi: 10.1016/j.cmet.2012.12.011</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Mendelsohn AR, Larrick JW. Dietary modification of the microbiome affects risk for cardiovascular disease. Rejuvenation Res. 2013 Jun;16(3):241-4. doi: 10.1089/rej.2013.1447</mixed-citation><mixed-citation xml:lang="en">Mendelsohn AR, Larrick JW. Dietary modification of the microbiome affects risk for cardiovascular disease. Rejuvenation Res. 2013 Jun;16(3):241-4. doi: 10.1089/rej.2013.1447</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Canyelles M, Tondo M, Cedo L, et al. Trimethylamine N-Oxide: A Link among Diet, Gut Microbiota, Gene Regulation of Liver and Intestine Cholesterol Homeostasis and HDL Function. Int J Mol Sci. 2018 Oct 19;19(10):3228. doi: 10.3390/ijms19103228</mixed-citation><mixed-citation xml:lang="en">Canyelles M, Tondo M, Cedo L, et al. Trimethylamine N-Oxide: A Link among Diet, Gut Microbiota, Gene Regulation of Liver and Intestine Cholesterol Homeostasis and HDL Function. Int J Mol Sci. 2018 Oct 19;19(10):3228. doi: 10.3390/ijms19103228</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu W, Gregory JC, Org E, et al. Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk. Cell. 2016 Mar 24;165(1):111-24. doi: 10.1016/j.cell.2016.02.011. Epub 2016 Mar 10.</mixed-citation><mixed-citation xml:lang="en">Zhu W, Gregory JC, Org E, et al. Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk. Cell. 2016 Mar 24;165(1):111-24. doi: 10.1016/j.cell.2016.02.011. Epub 2016 Mar 10.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Sun X, Jiao X, Ma Y, et al. Trimethylamine N-oxide induces inflammation and endothelial dysfunction in human umbilical vein endothelial cells via activating ROS-TXNIP-NLRP3 inflammasome. Biochem Biophys Res Commun. 2016 Dec 2;481(1-2):63-70. doi: 10.1016/j.bbrc.2016.11.017. Epub 2016 Nov 8.</mixed-citation><mixed-citation xml:lang="en">Sun X, Jiao X, Ma Y, et al. Trimethylamine N-oxide induces inflammation and endothelial dysfunction in human umbilical vein endothelial cells via activating ROS-TXNIP-NLRP3 inflammasome. Biochem Biophys Res Commun. 2016 Dec 2;481(1-2):63-70. doi: 10.1016/j.bbrc.2016.11.017. Epub 2016 Nov 8.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Singh GB, Zhang Y, Boini KM, Koka S. HighMobility Group Box 1 Mediates TMAO-Induced Endothelial Dysfunction. Int J Mol Sci. 2019 Jul 22;20(14):3570. doi: 10.3390/ijms20143570</mixed-citation><mixed-citation xml:lang="en">Singh GB, Zhang Y, Boini KM, Koka S. HighMobility Group Box 1 Mediates TMAO-Induced Endothelial Dysfunction. Int J Mol Sci. 2019 Jul 22;20(14):3570. doi: 10.3390/ijms20143570</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Komaroff AL. The Microbiome and Risk for Atherosclerosis. JAMA. 2018 Jun 19;319(23):2381-2. doi: 10.1001/jama.2018.5240</mixed-citation><mixed-citation xml:lang="en">Komaroff AL. The Microbiome and Risk for Atherosclerosis. JAMA. 2018 Jun 19;319(23):2381-2. doi: 10.1001/jama.2018.5240</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Skye SM, Zhu W, Romano KA, et al. Microbial Transplantation With Human Gut Commensals Containing CutC Is Sufficient to Transmit Enhanced Platelet Reactivity and Thrombosis Potential. Circ Res. 2018 Oct 26;123(10):1164-76. doi: 10.1161/CIRCRESA-HA.118.313142</mixed-citation><mixed-citation xml:lang="en">Skye SM, Zhu W, Romano KA, et al. Microbial Transplantation With Human Gut Commensals Containing CutC Is Sufficient to Transmit Enhanced Platelet Reactivity and Thrombosis Potential. Circ Res. 2018 Oct 26;123(10):1164-76. doi: 10.1161/CIRCRESA-HA.118.313142</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu W, Romano KA, Li L, et al. Gutmicrobes impact stroke severity via the trimethylamine N-oxide pathway. Cell Host Microbe. 2021 Jul 14;29(7):1199-208.e5. doi: 10.1016/j.chom.2021.05.002. Epub 2021 Jun 16.</mixed-citation><mixed-citation xml:lang="en">Zhu W, Romano KA, Li L, et al. Gutmicrobes impact stroke severity via the trimethylamine N-oxide pathway. Cell Host Microbe. 2021 Jul 14;29(7):1199-208.e5. doi: 10.1016/j.chom.2021.05.002. Epub 2021 Jun 16.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Swanepoel I, Roberts A, Brauns C, et al.Trimethylamine N-oxide (TMAO): a new attractive target to decrease cardiovascular risk. Postgrad Med J. 2022 Sep;98(1163):723-7. doi: 10.1136/postgradmedj-2021-139839. Epub 2021 Mar 31.</mixed-citation><mixed-citation xml:lang="en">Swanepoel I, Roberts A, Brauns C, et al.Trimethylamine N-oxide (TMAO): a new attractive target to decrease cardiovascular risk. Postgrad Med J. 2022 Sep;98(1163):723-7. doi: 10.1136/postgradmedj-2021-139839. Epub 2021 Mar 31.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Nie J, Xie L, Zhao BX, et al. Serum Trimethylamine N-Oxide Concentration Is Positively Associated With First Stroke in Hypertensive Patients. Stroke. 2018 Sep;49(9):2021-8. doi: 10.1161/STROKEAHA.118.021997. Erratum in: Stroke. 2019 Jun;50(6):e175.</mixed-citation><mixed-citation xml:lang="en">Nie J, Xie L, Zhao BX, et al. Serum Trimethylamine N-Oxide Concentration Is Positively Associated With First Stroke in Hypertensive Patients. Stroke. 2018 Sep;49(9):2021-8. doi: 10.1161/STROKEAHA.118.021997. Erratum in: Stroke. 2019 Jun;50(6):e175.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Tang WH, Wang Z, Li XS, et al. Increased Trimethylamine N-Oxide Portends High Mortality Risk Independent of Glycemic Control in Patients with Type 2 Diabetes Mellitus. Clin Chem. 2017 Jan;63(1):297-306. doi: 10.1373/clinchem.2016.263640. Epub 2016 Nov 18.</mixed-citation><mixed-citation xml:lang="en">Tang WH, Wang Z, Li XS, et al. Increased Trimethylamine N-Oxide Portends High Mortality Risk Independent of Glycemic Control in Patients with Type 2 Diabetes Mellitus. Clin Chem. 2017 Jan;63(1):297-306. doi: 10.1373/clinchem.2016.263640. Epub 2016 Nov 18.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Xu D, Zhao W, Song J, et al. The Relationship of Large-Artery Atherothrombotic Stroke with Plasma Trimethylamine N-Oxide Level and Blood Lipid-Related Indices: A Cross-Sectional Comparative Study. Biomed Res Int. 2021 Apr 22;2021:5549796. doi: 10.1155/2021/5549796</mixed-citation><mixed-citation xml:lang="en">Xu D, Zhao W, Song J, et al. The Relationship of Large-Artery Atherothrombotic Stroke with Plasma Trimethylamine N-Oxide Level and Blood Lipid-Related Indices: A Cross-Sectional Comparative Study. Biomed Res Int. 2021 Apr 22;2021:5549796. doi: 10.1155/2021/5549796</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Farhangi MA, Vajdi M, Asghari-Jafarabadi M.Gut microbiota-associated metabolite trimethylamine N-oxide and the risk of stroke: a systematic review and dose-response metaanalysis. Nutr J. 2020 Jul 30;19(1):76. doi: 10.1186/s12937-020-00592-2</mixed-citation><mixed-citation xml:lang="en">Farhangi MA, Vajdi M, Asghari-Jafarabadi M.Gut microbiota-associated metabolite trimethylamine N-oxide and the risk of stroke: a systematic review and dose-response metaanalysis. Nutr J. 2020 Jul 30;19(1):76. doi: 10.1186/s12937-020-00592-2</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Li Z, Hui J, Li S, et al. Trimethylamine N-oxide predicts stroke severity in diabetic patients with acute ischaemic stroke and is related to glycemic variability. Eur J Neurol. 2022 Jan 12. doi: 10.1111/ene.15249. Epub ahead of print.</mixed-citation><mixed-citation xml:lang="en">Li Z, Hui J, Li S, et al. Trimethylamine N-oxide predicts stroke severity in diabetic patients with acute ischaemic stroke and is related to glycemic variability. Eur J Neurol. 2022 Jan 12. doi: 10.1111/ene.15249. Epub ahead of print.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Xia F, Wen LP, Ge BC, et al. Gut microbiota as a target for prevention and treatment of type 2 diabetes: Mechanisms and dietary natural products. World J Diabetes. 2021 Aug 15;12(8):1146-63. doi: 10.4239/wjd.v12.i8.1146</mixed-citation><mixed-citation xml:lang="en">Xia F, Wen LP, Ge BC, et al. Gut microbiota as a target for prevention and treatment of type 2 diabetes: Mechanisms and dietary natural products. World J Diabetes. 2021 Aug 15;12(8):1146-63. doi: 10.4239/wjd.v12.i8.1146</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Xu J, Cheng A, Song B, et al. TrimethylamineN-Oxide and Stroke Recurrence Depends on Ischemic Stroke Subtypes. Stroke. 2022 Apr;53(4):1207-15. doi: 10.1161/STROKEAHA.120.031443. Epub 2021 Nov 19.</mixed-citation><mixed-citation xml:lang="en">Xu J, Cheng A, Song B, et al. TrimethylamineN-Oxide and Stroke Recurrence Depends on Ischemic Stroke Subtypes. Stroke. 2022 Apr;53(4):1207-15. doi: 10.1161/STROKEAHA.120.031443. Epub 2021 Nov 19.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Chen Y, Xu J, Pan Y, et al. Association of Trimethylamine N-Oxide and Its Precursor With Cerebral Small Vessel Imaging Markers. Front Neurol. 2021 Apr 1;12:648702. doi: 10.3389/fneur.2021.648702</mixed-citation><mixed-citation xml:lang="en">Chen Y, Xu J, Pan Y, et al. Association of Trimethylamine N-Oxide and Its Precursor With Cerebral Small Vessel Imaging Markers. Front Neurol. 2021 Apr 1;12:648702. doi: 10.3389/fneur.2021.648702</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Li X, Fan Z, Cui J, et al. TrimethylamineN-Oxide in Heart Failure: A Meta-Analysis of Prognostic Value. Front Cardiovasc Med. 2022 Feb 16;9:817396. doi: 10.3389/fcvm.2022.817396</mixed-citation><mixed-citation xml:lang="en">Li X, Fan Z, Cui J, et al. TrimethylamineN-Oxide in Heart Failure: A Meta-Analysis of Prognostic Value. Front Cardiovasc Med. 2022 Feb 16;9:817396. doi: 10.3389/fcvm.2022.817396</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Koszewicz M, Jaroch J, Brzecka A, et al.Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment. Pharmacol Res. 2021 Feb;164:105277. doi: 10.1016/j.phrs.2020.105277. Epub 2020 Nov 7.</mixed-citation><mixed-citation xml:lang="en">Koszewicz M, Jaroch J, Brzecka A, et al.Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment. Pharmacol Res. 2021 Feb;164:105277. doi: 10.1016/j.phrs.2020.105277. Epub 2020 Nov 7.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Roberts AB, Gu X, Buffa JA, et al.Development of a gut microbe-targeted nonlethal therapeutic to inhibit thrombosis potential. Nat Med. 2018 Sep;24(9):1407-17. doi: 10.1038/s41591-018-0128-1. Epub 2018 Aug 6.</mixed-citation><mixed-citation xml:lang="en">Roberts AB, Gu X, Buffa JA, et al.Development of a gut microbe-targeted nonlethal therapeutic to inhibit thrombosis potential. Nat Med. 2018 Sep;24(9):1407-17. doi: 10.1038/s41591-018-0128-1. Epub 2018 Aug 6.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Wang Z, Roberts AB, Buffa JA, et al. Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis. Cell. 2015 Dec 17;163(7):1585-95. doi: 10.1016/j.cell.2015.11.055</mixed-citation><mixed-citation xml:lang="en">Wang Z, Roberts AB, Buffa JA, et al. Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis. Cell. 2015 Dec 17;163(7):1585-95. doi: 10.1016/j.cell.2015.11.055</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Nam HS. Gut Microbiota and Ischemic Stroke: The Role of Trimethylamine N-Oxide. J Stroke. 2019 May;21(2):151-9. doi: 10.5853/jos.2019.00472. Epub 2019 May 31.</mixed-citation><mixed-citation xml:lang="en">Nam HS. Gut Microbiota and Ischemic Stroke: The Role of Trimethylamine N-Oxide. J Stroke. 2019 May;21(2):151-9. doi: 10.5853/jos.2019.00472. Epub 2019 May 31.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Konop M, Radkowski M, Grochowska M, et al. Enalapril decreases rat plasma concentration of TMAO, a gut bacteria-derived cardiovascular marker. Biomarkers. 2018 May-Jun;23(4):380-5. doi: 10.1080/1354750X.2018.1432689. Epub 2018 Feb 7.</mixed-citation><mixed-citation xml:lang="en">Konop M, Radkowski M, Grochowska M, et al. Enalapril decreases rat plasma concentration of TMAO, a gut bacteria-derived cardiovascular marker. Biomarkers. 2018 May-Jun;23(4):380-5. doi: 10.1080/1354750X.2018.1432689. Epub 2018 Feb 7.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Chen ML, Yi L, Zhang Y, et al. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)- Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota. mBio. 2016 Apr 5;7(2):e02210-15. doi: 10.1128/mBio.02210-15</mixed-citation><mixed-citation xml:lang="en">Chen ML, Yi L, Zhang Y, et al. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)- Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota. mBio. 2016 Apr 5;7(2):e02210-15. doi: 10.1128/mBio.02210-15</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Dambrova M, Skapare-Makarova E,Konrade I, et al. Meldonium decreases the dietincreased plasma levels of trimethylamine N-oxide, a metabolite associated with atherosclerosis. J Clin Pharmacol. 2013 Oct;53(10):1095-8. doi: 10.1002/jcph.135. Epub 2013 Jul 25.</mixed-citation><mixed-citation xml:lang="en">Dambrova M, Skapare-Makarova E,Konrade I, et al. Meldonium decreases the dietincreased plasma levels of trimethylamine N-oxide, a metabolite associated with atherosclerosis. J Clin Pharmacol. 2013 Oct;53(10):1095-8. doi: 10.1002/jcph.135. Epub 2013 Jul 25.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">McEntyre CJ, Lever M, Chambers ST, et al.Variation of betaine, N,N-dimethylglycine, choline, glycerophosphorylcholine, taurine and trimethylamine-N-oxide in the plasma and urine of overweight people with type 2 diabetes over a two-year period. Ann Clin Biochem. 2015 May;52(Pt 3):352-60. doi: 10.1177/0004563214545346. Epub 2014 Jul 10.</mixed-citation><mixed-citation xml:lang="en">McEntyre CJ, Lever M, Chambers ST, et al.Variation of betaine, N,N-dimethylglycine, choline, glycerophosphorylcholine, taurine and trimethylamine-N-oxide in the plasma and urine of overweight people with type 2 diabetes over a two-year period. Ann Clin Biochem. 2015 May;52(Pt 3):352-60. doi: 10.1177/0004563214545346. Epub 2014 Jul 10.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Кашух ЕА, Полуэктова ЕА, Кудрявцева АВи др. Влияние рифаксимина и мультиштаммового пробиотика на кишечный микробиом и показатели сердечно-сосудистого риска у пациентов с ишемической болезнью сердца. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2019;29(4):3849. doi: 10.22416/1382-4376-2019-29-4-38-49</mixed-citation><mixed-citation xml:lang="en">Kashukh EA, Poluektova EA, Kudryavtseva AV, et al. Effect of Rifaximin and a Multi-Strain Probiotic on the Intestinal Microbiome and Cardiovascular Risk Indicators in Patients with Coronary Heart Disease. Rossiyskiy zhurnal gastroenterologii, gepatologii, koloproktologii = Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2019;29(4):38-49. doi: 10.22416/1382-4376-2019-29-4-38-49 (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang H, Meng J, Yu H. Trimethylamine N-oxide Supplementation Abolishes the Cardioprotective Effects of Voluntary Exercise in Mice Fed a Western Diet. Front Physiol. 2017 Nov 23;8:944. doi: 10.3389/fphys.2017.00944</mixed-citation><mixed-citation xml:lang="en">Zhang H, Meng J, Yu H. Trimethylamine N-oxide Supplementation Abolishes the Cardioprotective Effects of Voluntary Exercise in Mice Fed a Western Diet. Front Physiol. 2017 Nov 23;8:944. doi: 10.3389/fphys.2017.00944</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
